Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel

Go back to Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel
(NASDAQ: ONCT) Delayed: 0.53 --0 (-0%)
Previous Close $0.53    52 Week High $ 
Open $0.53    52 Week Low $ 
Day High $0.53    P/E N/A 
Day Low $0.53    EPS $ 
Volume 161,794